Generic HIV Drugs

The financial pressures faced by HIV clinics in the NHS was a major theme of the recent British HIV Association conference. Doctors discussed how they can keep costs down without compromising the quality of care. One of the most important ways they can do so is to switch some patients from branded, expensive drugs to […]

Co-infection with HCV increases cancer risk for people with HIV

As a result of highly-active antiretroviral therapy (HAART), many people with HIV now have a near-normal life expectancy. However, rates of serious non-HIV-related illnesses are higher among people with HIV compared to individuals in the general population. Several studies have shown that even for people taking effective HAART, they have higher risk of several malignancies not traditionally associated […]

New version of Tenofovir

Tenofovir disoproxil fumarate (TDF) is one of the most widely used antiretroviral drugs. It is highly effective in treating HIV,and for most people, generally safe and well-tolerated. However, in a small minority of cases it can cause kidney problems. And TDF has an impact on bones…for most people, this is small and not noticeable, but […]

Two-drug Regimen Maintains Viral Suppression

Normal treatment for HIV involves taking three drug – so-called “triple therapy”, HAART, or cART. Whilst this is good for keeping the virus suppressed – so that the viral load is undetectable – taking three drugs can sometimes lead to side-effects. So work is being done to see if the drug burden can be reduced […]

Large Drop in HIV Diagnoses in London gay men 

  Four sexual health clinics serving large numbers of gay men in London have reported that they diagnosed far fewer gay men with HIV during 2016 than they did during 2015.  Many doctors believe that the use of pre-exposure prophylaxis (PrEP) is part of the explanation for these reductions. Such large drops in new diagnoses are […]

New form of tenofovir has good results for people aged 50+

One of the most widely used anti-HIV drugs is tenofovir disoproxil fumarate (TDF) – it is included in the tablets Viread, Truvada, Atripla, Eviplera and Stribild. TDF is highly effective and generally safe and well-tolerated, but can cause kidney and bone problems for some people. Tenofovir alafenamide (TAF) is a new form of the drug that is delivered more efficiently to […]

HIV: The Long View

A multi-disciplinary group of clinicians, experts and advocates in HIV have produced a report exploring how today’s trends in medical care and society might impact living with HIV in Western Europe in 20 years time. They say: HIV can no longer be just about prolonging life. For the HIV community, today’s challenge is making sure […]

Young people moving into adult HIV care

A small study from the Netherlands shows that adolescents living with HIV are especially likely to have problems with their HIV treatment when they move from paediatric to adult HIV services (typically around the age of 18). Several had problems adhering to their medication, stopped having an undetectable viral load or missed appointments. Problems were more […]